Metabolic and Other Diseases

  • David H. Dail


The entities discussed in this chapter are diverse. Many come under the heading of metabolic diseases, which may be congenital or acquired. Others are, or act through, an immunologic basis. A few have a single identifiable cause. Some represent a common tissue response to multiple identified causes, while others appear to have no known cause.


Pulmonary Hemorrhage Arch Pathol Alveolar Septum Relapse Polychondritis Pulmonary Alveolar Proteinosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hughes RAC, Berry CL, Seifert M. Relapsing polychondritis. Three cases with a clinicopathological study and literature review. Q J Med 1972; 41: 363–380.PubMedGoogle Scholar
  2. 2.
    Jaksch-Wartenhorst R. Polychondropathia. Wien Arch Intern Med 1923; 6: 93–100.Google Scholar
  3. 3.
    Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med 1960; 263: 51–58.PubMedCrossRefGoogle Scholar
  4. 4.
    McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976; 55: 193–215.CrossRefGoogle Scholar
  5. 5.
    Linck G, Porte A, Mantz JM, et al. Light and electron microscopic study of ear cartilage in a case of relapsing polychondritis evolving under corticoid treatment. Virchows Arch [A] 1981; 391: 301–308.CrossRefGoogle Scholar
  6. 6.
    Neild GH, Cameron JS, Lessof MH, Ogg CS, Turner DR. Relapsing polychondritis with crescentic glomerulo-nephritis. Br Med J 1978; 1: 743–745.PubMedCrossRefGoogle Scholar
  7. 7.
    Valenzuela R, Cooperrider PA, Gogate P, Deodhar SD, Bergfeld WF. Relapsing polychondritis: immunomicroscopic findings in cartilage of ear biopsy specimens. Hum Pathol 1980; 11: 19–22.PubMedCrossRefGoogle Scholar
  8. 8.
    Urbach E, Wiethe C. Lipoidosis cutis et mucosae. Virchows Arch Pathol Anat 1929; 273: 285–319.CrossRefGoogle Scholar
  9. 9.
    Caplan RM. Visceral involvement in lipoid proteinosis. Arch Dermatol 1967; 95: 149–155.PubMedCrossRefGoogle Scholar
  10. 10.
    Moscovic EA. Sarcoidosis and mycobacterial L-forms: a critical reappraisal of pleomorphic chromogenic bodies (Hamazaki corpuscles) in lymph nodes. Pathol Annu 1978; 13: 69–164.PubMedGoogle Scholar
  11. 11.
    Carstens PHB, Kùhns JG, Ghazi C. Primary malignant melanomas of the lung and adrenal. Hum Pathol 1984; 15: 910–914.PubMedCrossRefGoogle Scholar
  12. 12.
    Salm R. A primary malignant melanoma of the bronchus. J Pathol Bacteriol 1963; 85: 121–123.PubMedCrossRefGoogle Scholar
  13. 13.
    Allen MS Jr, Drash EC. Primary melanoma of the lung. Cancer 1968; 21: 154–159.PubMedCrossRefGoogle Scholar
  14. 14.
    Mennemeyer RP, Hammar SP, Tytus JS, Hallman KO, Raisis JE, Bockus D. Melanotic schwannoma: clinical and ultrastructural studies of three cases with evidence of intracellular melanin synthesis. Am J Surg Pathol 1979; 3: 3–10.PubMedCrossRefGoogle Scholar
  15. 15.
    Reiman HA, Koucky RF, Ecklung CM. Primary amyloidosis limited to tissue of mesodermal origin. Am J Pathol 1935; 11: 977–988.Google Scholar
  16. 16.
    Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal, immunoglobulins and Bence Jones proteins. N Engl J Med 1974; 290: 473–477.PubMedCrossRefGoogle Scholar
  17. 17.
    Duff GL, Murray EGD. Primary systemic amyloidosis. Am J Med Sci 1954; 328: 317–333.Google Scholar
  18. 18.
    Dahlin DC. Primary amyloidosis, with report of six cases. Am J Pathol 1949; 25: 105–123.PubMedGoogle Scholar
  19. 19.
    Smith RRL, Hutchins GM, Moore GW, Humphrey RL. Type and distribution of pulmonary parenchymal and vascular amyloid: Correlation with cardiac amyloidosis. Am J Med 1979; 66: 96–104.PubMedCrossRefGoogle Scholar
  20. 20.
    Toriumi J. The lung in generalized amyloidosis. Acta Pathol Jpn 1972; 22: 141–153.PubMedGoogle Scholar
  21. 21.
    Celli BR, Robinow A, Cohen AS, Brody JS. Patterns of pulmonary involvement in systemic amyloidosis. Chest 1978; 74: 543–547.PubMedCrossRefGoogle Scholar
  22. 22.
    Dahlin DC. Secondary amyloidosis. Ann Intern Med 1949; 31: 105–119.PubMedCrossRefGoogle Scholar
  23. 23.
    Briggs GW. Amyloidosis. Ann Intern Med 1961; 44: 943–957.CrossRefGoogle Scholar
  24. 24.
    Kuhlback B, Wegelius O. Secondary amyloidosis: a study of clinical and pathological findings. Acta Med Scand 1966; 180: 737–745.PubMedCrossRefGoogle Scholar
  25. 25.
    McGlennen RC, Burke BA, Dehner LP. Systemic amyloidosis complicating cystic fibrosis. Arch Pathol Lab Med 1968; 110: 879–884.Google Scholar
  26. 26.
    Pitkanen P, Westermark P, Cornwell GG. Senile systemic amyloidosis. Am J Pathol 1984; 117: 391–399.PubMedGoogle Scholar
  27. 27.
    Laden SA, Cohen ML, Harley RA. Nodular pulmonary amyloidosis with extrapulmonary involvement. Hum Pathol 1984; 15: 594–597.PubMedCrossRefGoogle Scholar
  28. 28.
    Rubinow A, Celli BR, Cohen AS, Rigden BG, Brody JS. Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis 1978; 118: 603–611.PubMedGoogle Scholar
  29. 29.
    Cohen AS. Amyloidosis. N Engl J Med 1967;177:522–530, 574–583, 628–638.Google Scholar
  30. 30.
    Klatskin G. Nonspecific green birefringence in Congo red-stained tissues. Am J Pathol 1969; 56: 1–12.PubMedGoogle Scholar
  31. 31.
    Glenner GG. Amyloid deposits and amyloidosis. The beta fibrilloses. N Engl J Med 1980;302: 1283–1291, 1333–1343.Google Scholar
  32. 32.
    Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore) 1975; 54: 271–299.Google Scholar
  33. 33.
    Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis: a histological method to assist in differentiating forms of disease. Lab Invest 1977; 235: 274–281.Google Scholar
  34. 34.
    Page DL, Isersky C, Harada M, Glenner GG. Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med (Berl) 1972; 159: 75–86.CrossRefGoogle Scholar
  35. 35.
    van Rijswijk MH, van Heusden CWGJ. The potassium permanganate method: a reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice. Am J Pathol 1979; 79: 43–54.Google Scholar
  36. 36.
    Hui AN, Koss MN, Hochholzer L, Wehunt WD. Amyloid presenting in the lower respiratory tract. Arch Pathol Lab Med 1986; 110: 212–218.PubMedGoogle Scholar
  37. 37.
    Thompson PJ, Citron KM. Amyloid and the lower respiratory tract. Thorax 1983; 38: 84–87.PubMedCrossRefGoogle Scholar
  38. 38.
    Lesser A. Ein fall von Enchondroma osteiodes mixtum der Lunge mit partieller amyloid entartung. Virchows Arch Pathol Anat 1877; 69: 404–408.CrossRefGoogle Scholar
  39. 39.
    Prowse CB. Amyloidosis of the lower respiratory tract. Thorax 1958; 13: 308–320.PubMedCrossRefGoogle Scholar
  40. 40.
    Balser W. Tracheo and Bronchialstenose mit Amyloid in der Wandungen der Leftwege. Virchows Arch Pathol Anat 1883; 91: 67–76.CrossRefGoogle Scholar
  41. 41.
    Dood AR, Mann JD. Primary diffuse amyloidosis of the respiratory tract. Arch Pathol Lab Med 1959; 67: 39–42.Google Scholar
  42. 42.
    Gottlieb LS, Gold WM. Primary tracheobronchial amyloidosis. Am Rev Respir Dis 1972; 105: 425–429.PubMedGoogle Scholar
  43. 42.
    Wilks S. Ossific deposits on larynx, trachea and bronchi. Trans Pathol Soc (London) 1857; 8: 88.Google Scholar
  44. 43.
    Alroy CG, Lichtig C, Kaftori JK. Tracheobronchopathia osteoplastica: end stage of primary pulmonary amyloidosis: Chest 1972; 61: 465–468.PubMedGoogle Scholar
  45. 45.
    Sakula A. Tracheobronchopathia osteoplastica: its relationship to primary tracheobronchial amyloidosis. Thorax 1968; 23: 105–110.PubMedCrossRefGoogle Scholar
  46. 45a.
    Martin CJ. Tracheobronchopathia osteochondroplastica. Arch Otolaryngol 1974; 100: 290–293.PubMedCrossRefGoogle Scholar
  47. 46.
    Firestone FN, Joison J. Amyloidosis: a cause of primary tumors of the lung. J Thorac Cardiovasc Surg 1966; 51: 292–299.PubMedGoogle Scholar
  48. 47.
    Lee S-C, Johnson HA. Multiple nodular pulmonary amyloidosis: a case report and comparison with diffuse alveolar-septal pulmonary amyloidosis. Thorax 1975; 30: 178–185.PubMedCrossRefGoogle Scholar
  49. 48.
    Desai RA, Mahajan VK, Benjami S, vanOrdstrand HS, Cordasco EM. Pulmonary amyloidoma and hilar adenopathy: rare manifestations of primary amyloidosis. Chest 1979; 76: 170–173.PubMedCrossRefGoogle Scholar
  50. 49.
    Saab SB, Burke J, Hupeman A, Almond C. Primary pulmonary amyloidosis: report of two cases. J Thorac Cardiovasc Surg 1974; 67: 301–307.PubMedGoogle Scholar
  51. 50.
    Becker BJP. Tumour-forming amyloidosis of the lung. Med Proc 1961; 7: 107–109.Google Scholar
  52. 51.
    Battaglia S, Masini T. Paramilodosi neoplastiforme del polmone. Folia Hered Pathol 1957; 6: 69–127.Google Scholar
  53. 52.
    Weiss L. Isolated multiple nodular pulmonary amyloidosis. Am J Clin Pathol 1960; 33: 318–329.PubMedGoogle Scholar
  54. 53.
    Himmelfarb E, Wells S, Rabinowitz JG. The radiologic spectrum of cardiopulmonary amyloidosis. Chest 1977; 72: 327–332.PubMedCrossRefGoogle Scholar
  55. 54.
    Fenoglio C, Pascal RR. Nodular amyloidosis of the lungs: an unusual case associated with chronic lung disease and carcinoma of the bladder. Arch Pathol 1970; 90: 577–582.PubMedGoogle Scholar
  56. 55.
    Case records of the Massachusetts General Hospital, Case 48–1977. N Engl J. Med 1977; 297: 1221–1228.CrossRefGoogle Scholar
  57. 56.
    Lundin D, Simonsson B, Winberg T. Pneumopleural amyloid tumour. Acta Radiol (Stockh) 1961; 55: 139144.Google Scholar
  58. 57.
    Gonzales-Cueto DM, Rigoli M, Gioseffi LM, Lancelle B, Martinez A. Diffuse pulmonary amyloidosis. Am J Med 1970; 48: 668–670.CrossRefGoogle Scholar
  59. 58.
    Poh SC, TO TS, Seah HC. Primary diffuse alveolar septal amyloidosis. Thorax 1975; 30: 186–191.PubMedCrossRefGoogle Scholar
  60. 59.
    Rajan VT, Kikkawa Y. Alveolar septal amyloidosis in primary amyloidosis: An electron microscopic study. Arch Pathol Lab Med 1970; 89: 521–525.Google Scholar
  61. 60.
    Naeye RL. Capillary and venous lesions in myxedema. Lab Invest 1963; 12: 465–470.PubMedGoogle Scholar
  62. 61.
    Gabrilove JL, Ludwig AW. The histogenesis of myxedema. J Clin Endocrinol Metabol 1957; 17: 925–932.CrossRefGoogle Scholar
  63. 62.
    Stanton MC, Tange JD. Goodpasture’s syndrome (pulmonary haemorrhage associated with glomerulonephritis). Aust Ann Med 1958; 7: 132–144.PubMedGoogle Scholar
  64. 63.
    Goodpasture EW. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 1919; 158: 863–870.CrossRefGoogle Scholar
  65. 64.
    Gavaghan TE, McNaught PJ, Ralston M, Hayes JM. Penicillamine-induced “Goodpasture’s syndrome”: successful treatment of a fulminant case. Aust NZ J Med 1981; 11: 261–265.Google Scholar
  66. 65.
    Rees AJ, Peters K, Amos N, Welsh KI, Batchelor JR. The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis. Kidney Int 1984; 26: 444–450.CrossRefGoogle Scholar
  67. 66.
    Benoit FL, Rulon DB, Theil GB, Doolan PD, Watten RH. Goodpasture’s syndrome: a clinicopathologic entity. Am J Med 1964; 37: 424–444.PubMedCrossRefGoogle Scholar
  68. 67.
    Zimmerman SW, Varanasi VR, Hoff B. Goodpasture’s syndrome with normal renal function. Am J Med 1971; 66: 163–171.CrossRefGoogle Scholar
  69. 68.
    Koffler D, Sandson J, Carr R, et al. Immunologic studies concerning the pulmonary lesions in Goodpasture’s syndrome. Am J Pathol 1969; 54: 293–305.PubMedGoogle Scholar
  70. 69.
    Border WA, Baehler RW, Bhathena D, Galssock RJ. IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med 1979; 91: 21–25.PubMedCrossRefGoogle Scholar
  71. 70.
    Weisland J, Bygren P, Heingard D. Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome. Proc Natl Acad Sci USA 1984; 81: 1544–1548.CrossRefGoogle Scholar
  72. 71.
    Fish AJ, Lockwood MC, Wong M, Price RG. Detection of Goodpasture antigen in fractions prepared from collagenase digests of human glomerular basement membrane. Clin Exp Immunol 1984; 55: 58–66.PubMedGoogle Scholar
  73. 72.
    Sisson S, Dysart NK, Fish AJ, Vernier RL. Localization of the Goodpasture antigen by immunoelectron microscopy. Clin Immunol Immunopathol 1982; 23: 414–429.PubMedCrossRefGoogle Scholar
  74. 73.
    Yaar M, Foidart JM, Brown KS, Rennard SI, Martin GR, Liotta L. The Goodpasture-like syndrome in mice induced by intravenous injections of anti-type IV collagen and anti-laminin antibody. Am J Pathol 1982; 107: 79–91.PubMedGoogle Scholar
  75. 74.
    Wieslander J, Langeveld J, Butkowski, Jodlowski M, Noelken M, Hudson BG. Physical and immunochemical studies of the glomerular domain of type IV collagen. J Biol Chem 1985; 260: 8564–8570.PubMedGoogle Scholar
  76. 75.
    Beechler CR, Enquist RW, Hunt KK, Ward GW, Kneser MR. Immunofluorescence of transbronchial biopsies in Goodpasture’s syndrome. Am Rev Respir Dis 1980; 121: 869–872.PubMedGoogle Scholar
  77. 76.
    Hogan PG, Donald KJ, McEvoy JDS. Immunofluorescence studies of lung biopsy tissue. Am Rev Respir Dis 1978; 118: 537–545.PubMedGoogle Scholar
  78. 77.
    Botting AJ, Brown AL, Divertie MD. The pulmonary lesion in a patient with Goodpasture’s syndrome as studied with the electron microscope. Am J Clin Pathol 1964; 42: 387–394.PubMedGoogle Scholar
  79. 78.
    Donald KJ, Edwards RL, McEvoy JDS. Alveolar capillary basement membrane lesions in Goodpasture’s syndrome and idiopathic pulmonary hemosiderosis. Am J Med 1975; 59: 642–649.PubMedCrossRefGoogle Scholar
  80. 79.
    Matthay RA, Bromberg SI, Putman CE. Pulmonary renal syndrome-a review. Yale J Biol Med 1980; 33: 497523.Google Scholar
  81. 80.
    Albelda SM, Gefter WB, Epstein DM, Miller WT. Diffuse pulmonary hemorrhage: A review and classification. Radiology 1985; 154: 289–297.PubMedGoogle Scholar
  82. 81.
    Leatherman IN, Davies SF, Hoidal JR. Alveolar hemorrhage syndromes: Diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine (Baltimore) 1984; 63: 343–361.Google Scholar
  83. 82.
    Goldstein J, Weil J, Liel Y. Intrapulmonary hemorrhages and immune complex glomerulonephritis masquerading as Goodpasture’s syndrome. Hum Pathol 1986; 17: 754–757.PubMedCrossRefGoogle Scholar
  84. 83.
    Soergel KH, Sommers SC. Idiopathic pulmonary hemosiderosis and related syndromes. Am J Med 1962; 32: 499–511.CrossRefGoogle Scholar
  85. 84.
    Waldenström J. Relapsing diffuse pulmonary bleeding or hemosiderosis pulmonum-a new clinical diagnosis. Acta Radiol (Stockh) 1944; 25: 149–162.CrossRefGoogle Scholar
  86. 85.
    Wynn-Williams N, Young RD. Idiopathic pulmonary hemosiderosis in adults. Thorax 1956; 11: 101–104.PubMedCrossRefGoogle Scholar
  87. 86.
    Boyd DHA. Idiopathic pulmonary hemosiderosis in adults and adolescents. Br J Dis Chest 1959; 53: 41–51.PubMedCrossRefGoogle Scholar
  88. 87.
    Bronson M. Idiopathic pulmonary hemosiderosis in adults: report of a case and review of the literature. AJR 1960; 83: 260–273.Google Scholar
  89. 88.
    Ognibene AJ, Johnson DE. Idiopathic pulmonary hemosiderosis in adults: report of case and review of literature. Arch Intern Med 1963; 111: 503–510.PubMedCrossRefGoogle Scholar
  90. 89.
    Morgan PGM, Turner-Warwick M. Pulmonary haemosiderosis and pulmonary hemorrhage. Br J Dis Chest 1981; 75: 225–242.PubMedCrossRefGoogle Scholar
  91. 90.
    Sprecace GA. Idiopathic pulmonary hemosiderosis: personal experience with six adults treated within a ten-month period and a review of the literature. Am Rev Respir Dis 1963; 88: 330–341.PubMedGoogle Scholar
  92. 91.
    Soergel KH, Sommers SC. The alveolar epithelial lesion of idiopathic pulmonary hemosiderosis. Am Rev Respir Dis 1962; 85: 540–552.Google Scholar
  93. 92.
    Hyatt RW, Adelstein ER, Halazun JF, Lukens JN. Ultra-structure of the lung in idiopathic pulmonary hemosiderosis. Am J Med 1972; 52: 822–829.PubMedCrossRefGoogle Scholar
  94. 93.
    Donald KJ, Edward RL, McEvoy JDS. Alveolar capillary basement membrane lesions in Goodpasture’s syndrome and idiopathic pulmonary hemosiderosis. Am J Med 1975; 59: 642–649.PubMedCrossRefGoogle Scholar
  95. 94.
    Irwin RS, Cottrell TS, Hsu KC, et al. Idiopathic pulmonary hemosiderosis: an electron microscopic and immunofluorescent study. Chest 1974; 65: 41–45.PubMedCrossRefGoogle Scholar
  96. 95.
    Donlan CJ Jr, Srodes CH, Duffy FD. Idiopathic pulmonary hemosiderosis: Electron microscopic, immunofluorescent and iron kinetic studies. Chest 1975; 68: 577580.Google Scholar
  97. 96.
    Gonzales-Crussi F, Hull MT, Grosfeld JL. Idiopathic pulmonary hemosiderosis: evidence of capillary basement membrane abnormality. Am Rev Respir Dis 1976; 114: 689–698.Google Scholar
  98. 97.
    Valassi-Adams H, Rouska A, Karpouzas J, Matsaniotis N. Raised IgA in idiopathic pulmonary hemosiderosis. Arch Dis Child 1975; 50: 320–322.CrossRefGoogle Scholar
  99. 98.
    Dail DH, Liebow AA, Gmelich J, Carrington CB, Churg A. A study of 43 cases of pulmonary veno-occlusive (PVO) disease. Lab Invest (abstr) 1978; 38: 340–341.Google Scholar
  100. 99.
    Walton KW, Heath D. Iron incrustation of the pulmo nary vessels in patent ductus arteriosus with congenital mitral disease. Br Heart J 1960; 22: 440–444.PubMedCrossRefGoogle Scholar
  101. 100.
    Walford RL, Kaplan L. Pulmonary fibrosis and giant-cell reaction with altered elastic tissue; endogenous pneumoconiosis. Arch Pathol Lab Med 1957; 63: 75–90.Google Scholar
  102. 101.
    Virchow R. Kalk-metastasen. Virchows Arch Pathol Anat 1855; 8: 103–113.CrossRefGoogle Scholar
  103. 102.
    Mulligan RM. Metastatic calcification. Arch Pathol Lab Med 1947; 43: 177–230.Google Scholar
  104. 103.
    Neff M, Yalcin S, Bupta S, Berger H. Extensive metastatic calcification of the lung in an azotemic patient. Am J Med 1974; 56: 103–109.PubMedCrossRefGoogle Scholar
  105. 104.
    Kuzela DC, Huffer WE, Conger JD, Winter SD, Hammond WS. Soft tissue calcification in chronic dialysis patients. Am J Pathol 1977; 86: 403–424.PubMedGoogle Scholar
  106. 105.
    Kaltreider HB, Baum GL, Bogaty G, McCoy MD, Tucker M. So-called “metastatic” calcifications of the lung. Am J Med 1969; 46: 188–196.PubMedCrossRefGoogle Scholar
  107. 106.
    Conger JD, Hammond WS, Alfrey AC, Coontiguglia SR, Stanford RE, Hufer WE. Pulmonary calcification in chronic dialysis patients. Ann Intern Med 1975; 83: 330–336.PubMedCrossRefGoogle Scholar
  108. 107.
    Wang N-S, Steele AA. Pulmonary calcification: scanning electron microscope and x-ray energy-dispersive analysis. Arch Pathol Lab Med 1979; 103: 252–257.PubMedGoogle Scholar
  109. 108.
    Smith JC, Stanton LW, Krammer NC, Parrish AE. Nodular pulmonary calcification in renal failure. Report of a case. Am Rev Respir Dis 1969; 100: 723–728.PubMedGoogle Scholar
  110. 109.
    McLachlan MSF, Wallace M, Seneviratne C. Pulmonary calcification in renal failure. Report of three cases. Br J Radiol 1968; 41: 99–106.PubMedCrossRefGoogle Scholar
  111. 110.
    Bonin M, Miyai K. Metastatic pulmonary calcification, morphology, chemical and x-ray microanalysis. Lab Invest 1977; 36: 331.Google Scholar
  112. 111.
    Davidson RC, Pendras JP. Calcium-related cardiorespiratory death in chronic hemodialysis. Trans Am Soc Artif Intern Organs 1967; 13: 36–40.Google Scholar
  113. 112.
    Firooznia H, Pudlowski R, Golimbu C, Rafii M, McCauley D. Diffuse interstitial calcification of the lungs in chronic renal failure mimicking pulmonary edema. AJR 1977; 129: 1103–1105.PubMedCrossRefGoogle Scholar
  114. 113.
    Koshy MC, Weinstein E, Pope RH, Boreyko C, Silverman D, Grant J. Calcific cardiomyopathy. N Engl J Med 1975; 292: 209–210.PubMedCrossRefGoogle Scholar
  115. 114.
    Boner G, Jacob ET, Pevzner S, Jungmann A. Diffuse calcification of lungs in a patient on maintenance hemodialysis. Isr J Med Sci 1971; 7: 1182–1187.PubMedGoogle Scholar
  116. 115.
    Felson B. Chest Roentgenography. Philadelphia: WB Saunders, 1973: 479.Google Scholar
  117. 116.
    Grames GM, Sauser DD, Jansen C, Soderblom RE, Hodgkin JE, Stilson MS. Radionuclide detection of diffuse interstitial pulmonary calcification. JAMA 1974; 230: 992–995.PubMedCrossRefGoogle Scholar
  118. 117.
    Wells HG. Calcification and ossification. Arch Intern Med 1911; 7: 721–753.CrossRefGoogle Scholar
  119. 118.
    Hueper W. Metastatic calcification in the organs of the dog after injection of parathyroid extract. Arch Pathol Lab Med 1927; 3: 14–25.Google Scholar
  120. 119.
    Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 209: 697–701.CrossRefGoogle Scholar
  121. 120.
    Heath D, Robertson AJ. Pulmonary calcinosis. Thorax 1977; 32: 606–611.PubMedCrossRefGoogle Scholar
  122. 121.
    Bestetti-Bosisio M, Cotelli F, Schiaffino E, Sorgato G, 141. Schmid C. Lung calcification in long-term dialysis patients: a light and electron microscopic study. Histopa- 142. thology 1984; 8: 69–79.CrossRefGoogle Scholar
  123. 122.
    Wagner E. Zahlreiche kleine Knochen in den Lungen. Arch Physiol Heilk (Stuttg) 1859; 35: 411.Google Scholar
  124. 123.
    Salinger H. Die Knochenbildungen in der Lunge mit besonderer Berücksichtigung der tuberösen Form. 143. Fortschr Geb Röntgenstra Ergänzungsband 1932; 46: 269–275.Google Scholar
  125. 124.
    Wells HG, Dunlap CE. Disseminated ossification of the 144. lungs. Arch Pathol Lab Med 1943; 35: 420–426.Google Scholar
  126. 125.
    Daust W. Über verästelte Knochenspangenbidung in der Lunge. Frankfurt Z Pathol 1929; 37: 313–327.Google Scholar
  127. 126.
    Müller KM, Kriemann J, Stichroth E. Dendriform pulmonary ossification. Pathol Res Pract 1980; 168: 163–172.PubMedCrossRefGoogle Scholar
  128. 127.
    Kuplic JB, Higley CS, Niewoehner DE. Pulmonary ossi- 146. fication associated with long-term busulfan therapy in chronic myelogenous leukemia. Am Rev Respir Dis 147. 1972; 106: 759–762.Google Scholar
  129. 128.
    Wilson WR, Sasaki R, Johnson CA. Disseminated nodu- 148. lar pulmonary ossification in patients with mitral steno-sis. Circulation 1959; 19: 323–331.PubMedCrossRefGoogle Scholar
  130. 129.
    Pear BL. Idiopathic disseminated pulmonary ossification. Radiology 1968; 91: 746–748.PubMedGoogle Scholar
  131. 130.
    Epstein EJ, Chapman R, Coulshed N, Galloway RW. 150. Pulmonary ossific nodule formation in the absence of mitral valve disease: a report of four cases. Am J Heart 1963; 65: 816–825. 151.Google Scholar
  132. 131.
    Galloway RW, Epstein EJ, Coulshed N. Pulmonary ossific nodules in mitral valve disease. Br Heart J 1961; 23: 297–307. 152.Google Scholar
  133. 132.
    Daugavietis HE, Mautner LS. Disseminated nodular pulmonary ossification with mitral stenosis. Arch Pathol 153. Lab Med 1957; 63: 7–12.Google Scholar
  134. 133.
    Elkeles A, Glynn LE. Disseminated parenchymatous ossification in the lungs in association with mitral stenosis. 154. J Pathol Bacteriol 1946; 58: 517–522.PubMedCrossRefGoogle Scholar
  135. 134.
    Popelka CG, Kleinerman J. Diffuse pulmonary ossifica- 155. tion. Arch Intern Med 1977; 137: 523–525.PubMedCrossRefGoogle Scholar
  136. 135.
    Green JD, Harle TS, Greenberg SD, Weg JG, Nevin H, Jenkins DE. Disseminated pulmonary ossification: 156. a case report with demonstration of electron microscopic features. Am Rev Respir Dis 1970; 101: 293–298. 157.Google Scholar
  137. 136.
    Lendrum AC, Scott LDW, Parks SDS. Pulmonary changes due to cardiac diseases, with special reference to hemosiderosis. Q J Med 1950; 19: 249–262. 158.Google Scholar
  138. 137.
    Katzenstein A-L A, Askin FB. Surgical pathology of non-neoplastic lung disease. Philadelphia; WB Saun- 159. ders, 1982: 371.Google Scholar
  139. 138.
    Kuhn C III, Kuo T-T. Cytoplasmic hyalin in asbestosis: a reaction of injured alveolar epithelium. Arch Pathol Lab Med 1973; 95: 190–194. 160.Google Scholar
  140. 139.
    Phillips MJ. Mallory bodies and the liver. Lab Invest 1982; 47: 31 1–313.Google Scholar
  141. 140.
    Warnock ML, Press M, Churg A. Further observations on cytoplasmic hyaline in the lung. Hum Pathol 1980; 11: 59–65.PubMedCrossRefGoogle Scholar
  142. 141.
    Personal communication. Samuel P. Hammar, M.D., Seattle, Washington, 1986.Google Scholar
  143. 142.
    Denk A, Franke WW, Eckerstrofer R, Schmid E, Kerjaschdi D. Formation and involution of Mallory bodies “alcoholic hyalin” in marine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin. Proc Nat Acad Sci USA 1979; 76: 4112–4116.PubMedCrossRefGoogle Scholar
  144. 143.
    Michel RP, Limacher JJ, Kimoff RJ. Mallory bodies in scar adenocarcinoma of the lung. Hum Pathol 1982; 13: 81–85.PubMedCrossRefGoogle Scholar
  145. 144.
    Dekker A, Krause JR. Hyaline globules in human neoplasms: a report of three autopsy cases. Arch Pathol Lab Med 1973; 95: 178–181.Google Scholar
  146. 145.
    Prakash UBS, Barham SS, Rosenow EC III, Brown ML, Payne WS. Pulmonary alveolar microlithiasis: a review including ultrastructural and pulmonary function studies. Mayo Clin Proc 1983; 58: 290–300.PubMedGoogle Scholar
  147. 146.
    Michaels L, Levene C. Pulmonary corpora amylacea. J Pathol Bacteriol 1957; 74: 49–56.CrossRefGoogle Scholar
  148. 147.
    Harbitz F. Extensive calcification of the lungs as a distinct disease. Arch Intern Med 1918; 21: 139–146.CrossRefGoogle Scholar
  149. 148.
    Puhr L. Mikrolithiasis alveolaris pulmonum. Virchows Arch Pathol Anat 1933; 290: 156–160.CrossRefGoogle Scholar
  150. 149.
    Sosman MC, Dodd GD, Jones WD, Pillmore GU. The familial occurrence of pulmonary alveolar microlithiasis. AJR 1957; 77: 947–1012.Google Scholar
  151. 150.
    Caffrey PR, Altman RS. Pulmonary alveolar microlithiasis occurring in premature twins. J Pediatr 1965; 66: 758763.Google Scholar
  152. 151.
    Thurairajasingam S, Dhrmasena BD, Kasthuriratna T. Pulmonary alveolar microlithiasis. Australas Radio! 1975; 19: 175–180.CrossRefGoogle Scholar
  153. 152.
    Thind GS, Bhatia JL. Pulmonary alveolar microlithiasis. Br J Dis Chest 1978; 72: 151–154.PubMedCrossRefGoogle Scholar
  154. 153.
    Drinkovic I, Strohal K, Sabljica B. Mikrolithiasis alveolaris pulmonum. Fortschr Geb Rontgenstr Nuklearmed Erganzungsband 1962; 97: 180–185.CrossRefGoogle Scholar
  155. 154.
    Mikhailov V. Pulmolithiasis endoalveolaris et interstitialis diffusa. Klin Med (Mosk) 1954; 32: 31–36.Google Scholar
  156. 155.
    Kino T, Kohara Y, Tsuji S. Pulmonary alveolar microlithiasis: a report of two young sisters. Am Rev Respir Dis 1972; 105: 105–110.PubMedGoogle Scholar
  157. 156.
    Sears MR, Chang AR, Taylor AJ. Pulmonary alveolar microlithiasis. Thorax 1971; 26: 704–711.PubMedCrossRefGoogle Scholar
  158. 157.
    Puleihan FJD, Abboud RT, Balikian JP, Nucho CFN. Pulmonary alveolar microlithiasis: Lung function in five cases. Thorax 1969; 24: 84–90.CrossRefGoogle Scholar
  159. 158.
    Biressi PC, Casassa PM. La microlitiasi polmonare endoalveolare. Minerva Med 1956; 47: 930–939.PubMedGoogle Scholar
  160. 159.
    Shigeno C, Fukunaga M, Morita R, Maeda H. Hino M, Torizuka K. Bone scintigraphy in pulmonary alveolar microlithiasis: a comparative study of radioactivity and density distribution. Clin Nucl Med 1982; 7: 103–107.PubMedCrossRefGoogle Scholar
  161. 160.
    Brown ML, Swee RG, Olson RJ, Bender CE. Pulmonary Uptake of 99mTC diphosphonate in alveolar microlithiasis. AJR 1978; 131: 703–704.PubMedCrossRefGoogle Scholar
  162. 161.
    Tao L-C. Microliths in sputum specimens and their relationship to pulmonary alveolar microlithiasis. Am J Clin Pathol 1978; 69: 482–485.PubMedGoogle Scholar
  163. 162.
    Palombini BC, da Silva Porto N, Wallau CU, Camargo J!. Bronchopulmonary lavage in alveolar microlithiasis. Chest 1981; 80: 242–243.PubMedCrossRefGoogle Scholar
  164. 163.
    Sharp ME, Danino EA. An unusual form of pulmonary calcification: “Microlithiasis alveolaris pulmonum. ” J Pathol Bacteriol 1953; 389–399.Google Scholar
  165. 164.
    Kent G, Gilbert ES, Meyer HH. Pulmonary microlithiasis: microlithiasis alveolaris pulmonum. Arch Pathol Lab Med 1955; 60: 536–562.Google Scholar
  166. 165.
    Kawakami M, Sato S, Takashima T. Electron microscopic studies on pulmonary alveolar microlithiasis. Tohoku J Exp Med 1978; 126: 343–361.PubMedCrossRefGoogle Scholar
  167. 166.
    Bab I, Rosenmann E, Ne’eman Z, Sela J. The occurrence of extracellular matrix vesicles in pulmonary alveolar microlithiasis. Virchows Arch [A] 1981; 391: 357–361.CrossRefGoogle Scholar
  168. 167.
    Greenberg MJ. Miliary shadows in the lungs due to microlithiasis alveolaris pulmonum. Thorax 1957; 12: 171–174.PubMedCrossRefGoogle Scholar
  169. 168.
    Friedreich N. Kleinere mittheilungen: I. Corpora amylacea in den lungen. Virch Arch Pathol Anat 1856; 9: 613–618.CrossRefGoogle Scholar
  170. 169.
    Lubarsch O, Plenge K. Die corpora amylacea. In: Hemke E, Lubarsch O. eds. Handb der spezielle pathol Anat u Hist. Vol. 3, Part 3. Berlin: Springer-Verlag, 1931: 607–654.Google Scholar
  171. 170.
    Michaels L, Levene C. Pulmonary corpora amylacea. J Pathol Bacteriol 1957; 74: 49–56.CrossRefGoogle Scholar
  172. 171.
    Hollander DH, Hutchins GM. Central spherules in pulmonary corpora amylacea. Arch Pathol Lab Med 1978; 100: 629–630.Google Scholar
  173. 172.
    Baar HS, Ferguson FF. Microlithiasis alveolaris pulmonum: association with diffuse interstitial pulmonary fibrosis. Arch Pathol Lab Med 1963; 76: 659–666.Google Scholar
  174. 173.
    Steele HD, Kinley G, Leuchtenberger C, Lieb E. Polysaccharide nature of corpora amylacea. Arch Pathol Lab Med 1952; 54: 94–97.Google Scholar
  175. 174.
    Dail DH, Liebow AA. Intraalveolar conchoidal bodies. Am J Pathol 1974; 76: 43A (abstr).Google Scholar
  176. 175.
    Michaels L. Lung changes in woodworkers. Can Med Assoc J 1967; 96: 1150–1155.PubMedGoogle Scholar
  177. 176.
    Gardiner IT, UffJS. “Blue bodies” in case of cryptogenic fibrosing alveolitis (desquamative type)-an ultrastructural study. Thorax 1978; 33: 806–813.PubMedCrossRefGoogle Scholar
  178. 177.
    Koss MN, Johnson FB, Hochholzer L. Pulmonary blue bodies. Hum Pathol 1981; 12: 258–266.PubMedCrossRefGoogle Scholar
  179. 178.
    Kim CK, Goyal PC, Payne CB Jr. Pulmonary blue bodies. Hum Pathol 1983; 14: 739–740.PubMedGoogle Scholar
  180. 179.
    Kung ITM, Johnson FB, So S-Y, Lam W-K, Hsu C. Blue bodies in cytology specimens in a case of pulmonary talcosis. Am J Clin Pathol 1984; 81: 675–678.PubMedGoogle Scholar
  181. 180.
    Williams WJ. The nature and origin of Schaumann bodies. J Pathol Bacteriol 1960; 79: 193–201.CrossRefGoogle Scholar
  182. 181.
    Williams WJ, Williams D. The properties and development of conchoidal bodies in sarcoid and sarcoid-like granulomas. J Pathol Bacteriol 1968; 96: 491–496.PubMedCrossRefGoogle Scholar
  183. 182.
    Tao I.C. Microliths in sputum specimens and their relationship to pulmonary alveolar microlithiasis. Am J Clin Pathol 1978; 69: 482–485.PubMedGoogle Scholar
  184. 183.
    Pritzker KPH, Desai SD, Patterson MC, Cheng P-T. Calcite sputum with characterization by analytic scanning electron microscopy and x-ray diffraction. Am J Clin Pathol 1981; 75: 253–257.PubMedGoogle Scholar
  185. 184.
    Koss MN, Huchholzer L, Feigin DS, Gavancis JC, Ward PA. Necrotizing sarcoid-like granulomatosis: clinical, pathologic and immunopathologic findings. Hum Pathol 1980; 11: 510–519.PubMedGoogle Scholar
  186. 185.
    Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123–1142.PubMedCrossRefGoogle Scholar
  187. 186.
    Davidson JM, Macleod WM. Pulmonary alveolar proteinosis. Br J Dis Chest 1969; 63: 13–28.PubMedCrossRefGoogle Scholar
  188. 187.
    Gough J. Silicosis and alveolar proteinosis. Br Med J 1967; 1: 629.PubMedCrossRefGoogle Scholar
  189. 188.
    Buechner HA, Ansari A. Acute silicoproteinosis: a new physiologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest 1969; 55: 274–284.PubMedCrossRefGoogle Scholar
  190. 189.
    Hoffman EO, Lamberty J, Pizzolato P. The ultra-structure of acute silicosis. Arch Pathol Lab Med 1973; 96: 104–107.Google Scholar
  191. 190.
    Xipell JM, Ham KN, Price CG, Thomas DP. Acute silicolipoproteinosis. Thorax 1977; 32: 104–111.PubMedCrossRefGoogle Scholar
  192. 191.
    Suratt PM, Winn WC Jr, Brody AR, Bolton WK, Giles RD. Acute silicosis in tombstone sandblasters. Am Rev Respir Dis 1977; 115: 521–529.PubMedGoogle Scholar
  193. 192.
    Miller RR, Churg AM, Hutcheon M, Lam S. Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 1984; 130: 312–315.PubMedGoogle Scholar
  194. 193.
    Abraham JL, Auchincloss JH. Pulmonary alveolar proteinosis and kaolin exposure. Am Rev Respir Dis 1985; 131: A208 (abstr).Google Scholar
  195. 194.
    Gross P, deTreville RTP. Alveolar proteinosis: its experimental production in rodents. Arch Pathol Lab Med 1968; 86: 255–261.Google Scholar
  196. 195.
    Corrin B, King E. Experimental endogenous lipid pneumonia and silicosis. J Pathol 1969; 97: 325–330.PubMedCrossRefGoogle Scholar
  197. 196.
    Heppleston AG, Wright NA, Stewart JA. Experimental alveolar lipoproteinosis following the inhalation of silica. J Pathol 1970; 101: 293–307.PubMedCrossRefGoogle Scholar
  198. 197.
    Heppleston AG, Young AE. Alveolar lipo-proteinosis: Un ultrastructural comparison of the experimental and human forms. J Pathol 1972; 107: 107–117.PubMedCrossRefGoogle Scholar
  199. 198.
    Martin TR, Wehner AP, Butler J. Pulmonary toxicity of Mt St Helens volcanic ash. Am Rev Respir Dis 1983; 128: 158–162.PubMedGoogle Scholar
  200. 199.
    Corrin B, King E. Pathogenesis of experimental alveolar proteinosis. Thorax 1970; 25: 230–236.PubMedCrossRefGoogle Scholar
  201. 200.
    Gross P. Harley RA Jr, deTreville RTP. Pulmonary reaction to metallic aluminum powders: an experimental study. Arch Environ Health 1973; 26: 227–255.Google Scholar
  202. 201.
    Lee KP, Barris CE, Griffith FD, Waritz RS. Pulmonary response to glass fiber by inhalation exposure. Lab Invest 1979; 40: 123–133.PubMedGoogle Scholar
  203. 202.
    Vijeyaratnam GS, Corrin B. Pulmonary alveolar proteinosis developing from desquamative interstitial pneumonia in long term toxicity studies of iprindole in the rat. Virchows Arch [A] 1973; 358: 1–10.CrossRefGoogle Scholar
  204. 203.
    Lüllmann-Rauch R, Reil GH, Rossen E, Seiler KU. The ultrastructure of rat lung changes induced by an anorectic drug (Chlorphentermine). Virchows Arch [Zellpathol] 1972; 11: 167–181.Google Scholar
  205. 204.
    Heath D, Smith P, Hasleton PS. Effects of chlorphentermine on the rat lung. Thorax 1973; 28: 551–558.PubMedCrossRefGoogle Scholar
  206. 205.
    Smith P, Heath D, Hasleton PS. Electron microscopy of chlorphentermine lung. Thorax 1973; 28: 559–566.PubMedCrossRefGoogle Scholar
  207. 206.
    Schober R, Kosek JC, Bensch KG. Origin of the membraneous intraalveolar material in pulmonary alveolar proteinosis. Lab Invest 1974; 30: 388–389.Google Scholar
  208. 207.
    Likhaechev IuP, Batsura IuD, Direev VI. The role of some occupational factors in the development of pulmonary alveolar proteinosis. Arkh Patol 1975; 37: 63–69.Google Scholar
  209. 208.
    Vallyathan V, Reasor M, Schwegler D, Stettler L. Comparative in vitro cytotoxicity and relative pathogenicity of mineral dusts. Ann Occup Hyg 1987 (in press).Google Scholar
  210. 209.
    McEuen DD, Abraham JL. Particulate concentrations in pulmonary alveolar proteinosis. Environ Res 1978; 17: 334–339.PubMedCrossRefGoogle Scholar
  211. 210.
    Abraham JL, McEuen DD. Inorganic particulates associated with pulmonary alveolar proteinosis: SEM and x-ray microanalysis results. Appl Pathol 1987 (in press).Google Scholar
  212. 211.
    Larson RK, Gordinier R. Pulmonary alveolar proteinosis: report of six cases, review of the literature, and formulation of a new theory. Ann Intern Med 1965; 62: 292–312.PubMedCrossRefGoogle Scholar
  213. 212.
    Lakshminarayan S. Schwartz MI, Standford RE. Unsuspected pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Chest 1976; 69: 433–435.CrossRefGoogle Scholar
  214. 213.
    Bedrossian CWM, Luna MA, Conklin RH, Miller WC. Alveolar proteinosis as a consequence of immunosuppression: a hypothesis based on clinical and pathologic observations. Hum Pathol 1980; 11: 527–535.PubMedGoogle Scholar
  215. 214.
    Doyle AP, Balcerzak SP, Wells CL, Crittenden JO. Pulmonary alveolar proteinosis with hematologic disorders. Arch Intern Med 1963; 112: 940–946.PubMedCrossRefGoogle Scholar
  216. 215.
    Haworth JC, Hoogstraten J, Taylor H. Thymic alymphoplasia. Arch Dis Child 1967; 42: 40–54.PubMedCrossRefGoogle Scholar
  217. 216.
    Jean R, Nezelof C, Bonnett H, et al. Protéinose alvéolaire et inclusions cytomégaliques pulmonaires au cours de l’alymphoplasie thymique. Arch Franc Pediatr 1968; 25: 1009–1021.Google Scholar
  218. 217.
    Colon AR, Lawrence RD, Mills SD, O’Connell EJ. Childhood pulmonary alveolar proteinosis (PAP): report of a case and review of the literature. Am J Dis Child 1971; 121: 481–485.PubMedGoogle Scholar
  219. 218.
    Webster JR Jr, Battifora H, Furey C, Harrison RA, Shapiro B. Pulmonary alveolar proteinosis in two siblings With decreased immunoglobulin A. Am J Med 1980; 69: 786–789.PubMedCrossRefGoogle Scholar
  220. 219.
    Coleman M, Dehner LP, Sibley SK, Burke BA, L’Heureux PR, Thompson TR. Pulmonary alveolar proteinosis: an uncommon cause of chronic neonatal distress. Am Rev Respir Dis 1980; 121: 583–586.PubMedGoogle Scholar
  221. 220.
    Knight DP, Knight JA. Pulmonary alveolar proteinosis in the newborn. Arch Pathol Lab Med 1985; 109: 529–531.PubMedGoogle Scholar
  222. 221.
    Steer A. Focal pulmonary alveolar proteinosis in pulmonary tuberculosis. Arch Pathol Lab Med 1969; 87: 347352.Google Scholar
  223. 222.
    Payseur CR, Konwaler BE, Hyde L. Pulmonary alveolar proteinosis. Am Rev Tuberc 1958; 79: 906–915.Google Scholar
  224. 223.
    Reyes J M, Putong PB. Association of pulmonary alveolar lipoproteinosis with mycobacterial infection. Am J Clin Pathol 1980; 74: 478–485.PubMedGoogle Scholar
  225. 224.
    Sanguigno N, Campesi G. Proteinosi alveolare ad evoluzione in sclerosi polmonare di tipo clinicamente idiopatico. Riv Tuberc Mal 1961; 9: 463.Google Scholar
  226. 225.
    Sunderland WA, Campbell RA, Edward MJ. Pulmonary alveolar proteinosis and pulmonary cryptococcosis in an adolescent boy. J Pediatr 1972; 80: 450–456.PubMedCrossRefGoogle Scholar
  227. 226.
    Teja K, Cooper PH, Squires JE, Schnatterly PT. Pulmonary alveola proteinosis in four siblings. N Engl J Med 1981; 305: 1390–1392.PubMedCrossRefGoogle Scholar
  228. 227.
    Preger L. Pulmonary alveolar proteinosis. Radiology 1969; 92: 1291–1295.PubMedGoogle Scholar
  229. 228.
    Corsello BF, Choi H. Basophilic staining in pulmonary alveolar proteinosis: Report of three cases. Arch Pathol Lab Med 1984; 108: 68–70.PubMedGoogle Scholar
  230. 229.
    William GE, Medley DR, Brown R. Pulmonary alveolar proteinosis. Lancet 1960;i:1385–1388.Google Scholar
  231. 230.
    Sieraki JL, Horn RC Jr, Kay S. Pulmonary alveolar proteinosis: report of three cases. Ann Intern Med 1959; 51: 728–739.CrossRefGoogle Scholar
  232. 231.
    Kuhn C III, Gyorkey F, Levine BE, Ramirez-Rivera J. Pulmonary alveolar proteinosis, a study using enzyme histochemistry, electron microscopy and surface tension measurement. Lab Invest 1966; 15: 492–509.PubMedGoogle Scholar
  233. 232.
    Basset F, Soler P, Turiaf J. Etude ultrastructurale du contenu alveolaire dans la protéinose alvéolaire pulmonaire et dans les pseudoprotéinoses. Ann Med Interne (Paris) 1973; 24: 279–290.Google Scholar
  234. 233.
    Costella JF, Moriarity DC, Branthwaite A, Turner-Warwick M, Corrin B. Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax 1975; 30: 121–132.CrossRefGoogle Scholar
  235. 234.
    Singh G, Katyal S. Surfactant apoprotein in normalignant pulmonary disorders. Am J Pathol 1980; 101: 5162.Google Scholar
  236. 235.
    Singh G, Katyal SL, Bedrossian CWM, Rogers RM. Pulmonary alveola proteinosis: staining of surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest 1983; 83: 82–86.PubMedCrossRefGoogle Scholar
  237. 236.
    Ramirez J, Harlan WR Jr. Pulmonary alveolar proteinosis, nature and origin of alveolar lipid. Am J Med 1968; 45: 502–512.PubMedCrossRefGoogle Scholar
  238. 237.
    McClenahan JB, Mussenden R. Pulmonary alveolar proteinosis. Arch Intern Med 1974; 133: 284–287.PubMedCrossRefGoogle Scholar
  239. 238.
    Hawkins JE, Savard EV, Ramirez-Rivera J. Pulmonary alveolar proteinosis: origin of proteins in pulmonary washings. Am J Clin Pathol 1967; 48: 14–17.PubMedGoogle Scholar
  240. 239.
    Hook GER, Bell DY, Gilmore LB, Nadeau D, Reasor MJ, Talley FA. Composition of bronchoalveolar lavage effluents from patients with pulmonary alveolar proteinosis. Lab Invest 1978; 39: 342–357.PubMedGoogle Scholar
  241. 240.
    Stansifer PP, Bourgeois C. Pulmonary alveolar proteinosis: histochemical observations. Am J Clin Pathol 1965; 44: 539–545.PubMedGoogle Scholar
  242. 241.
    Ray RL, Salm R. A fatal case of pulmonary alveolar proteinosis. Thorax 1962; 17: 257–266.PubMedCrossRefGoogle Scholar
  243. 242.
    Bell DY, Hook GER. Pulmonary alveolar proteinosis: analysis of airway and alveolar proteins. Am Rev Respir Dis 1979; 119: 979–990.PubMedGoogle Scholar
  244. 243.
    Heppleston AG, Fletcher K, Wyatt I. Changes in the composition of the lung lipids and the “turnover” of diplmitoyl lecithin in experimental alveolar lipo-proteinosis induced by inhaled quartz. Br J Exp Pathol 1974; 55: 384–395.PubMedGoogle Scholar
  245. 244.
    Hook GER, Gilmore LB, Talley FA. Multilamellated structures from the lungs of patients with pulmonary alveolar proteinosis. Lab Invest 1984; 50: 711–725.PubMedGoogle Scholar
  246. 245.
    Smith FB. Alveolar proteinosis: atypical pulmonary response to injury. NY State J Med 1980; 80: 1372–1380.Google Scholar
  247. 246.
    Golde DW, Territo M, Finley TN, Cline MJ. Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 1976; 85: 304–309.PubMedCrossRefGoogle Scholar
  248. 247.
    Harris JO. Pulmonary alveolar proteinosis: abnormal in vitro function of alveolar macrophages. Chest 1979; 76: 156–159.PubMedCrossRefGoogle Scholar
  249. 248.
    Nugent KM, Pesanti EL. Macrophage function in pulmonary alveolar proteinosis. Am Rev Respir Dis 1983; 127: 780–781.PubMedGoogle Scholar
  250. 249.
    Ansfield MJ, Kaltreider HB, Benson BJ, Shalaby MR. Canine surface active material and pulmonary lymphocyte function: studies with mixed lymphocyte culture. Exp Lung Res 1980; 1: 3–11.PubMedCrossRefGoogle Scholar
  251. 250.
    Ramirez-R J, Savard EV, Hawkins JE. Biological effects of pulmonary washings from cases of alveolar proteinosis. Am Rev Respir Dis 1966; 94: 244–246.Google Scholar
  252. 251.
    Ramirez-R J. Bronchopulmonary lavage: new techniques and observations. Dis Chest 1966, 50: 581–588.CrossRefGoogle Scholar
  253. 252.
    Ramirez-R J. Alveolar proteinosis: importance of pulmonary lavage. Am Rev Respir Dis 1971; 103: 666–678.Google Scholar
  254. 253.
    Claque HW, Wallace AC, Morgan WKC. Pulmonary interstitial fibrosis associated with alveolar proteinosis. Thorax 1983; 38: 865–866.CrossRefGoogle Scholar
  255. 254.
    Fraimow W, Cathcart RT, Kirshner JJ, Taylor RC. Pulmonary alveolar proteinosis: a correlation of pathological and physiological findings in a patient followed up with serial biopsies of the lung. Am J Med 1960; 28: 458–467.PubMedCrossRefGoogle Scholar
  256. 255.
    Liebow AA. Desquamative interstitial pneumonia. Am J Pathol 1962; 41: 127 (title only).Google Scholar
  257. 256.
    Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965; 39: 369–404.PubMedCrossRefGoogle Scholar
  258. 257.
    Herbert FA, Nahmias BB, Gaensler EA, McMahon HE. Pathophysiology of interstitial pulmonary fibrosis. Arch Intern Med 1962; 110: 626–648.Google Scholar
  259. 258.
    Gaensler EA, Goff AM, Prowse CM. Desquamative interstitial pneumonia. N Engl J Med 1966; 274: 113–128.PubMedCrossRefGoogle Scholar
  260. 259.
    Scadding JG, Hinson KFW. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis. Thorax 1967; 22: 291–304.PubMedCrossRefGoogle Scholar
  261. 260.
    Bates DV, Christie RV. Respiratory function in disease. Philadelphia: WB Saunders, 1964: 298–303.Google Scholar
  262. 261.
    Leroy EP. The blood-air barrier in desquamative interstitial pneumonia (D.I.P.). Virchows Arch Pathol Anat 1969; 348: 117–130.CrossRefGoogle Scholar
  263. 262.
    Brewer DB, Heath D, Asquith P. Electron microscopy of desquamative interstitial pneumonia. J Pathol 1969; 97: 317–323.PubMedCrossRefGoogle Scholar
  264. 263.
    Farr GH, Harley RA, Hennigar GR. Desquamative interstitial pneumonia: an electron microscopic study. Am J Pathol 1970; 60: 347–354.PubMedGoogle Scholar
  265. 264.
    Vijeyaratnam GS, Corrin B. Pulmonary histiocytosis simulating desquamative interstitial pneumonia in rats receiving oral iprindole. Thorax 1972; 108: 105–113.Google Scholar
  266. 265.
    Corrin B, Price AB. Electron microscopy studies in desquamative interstitial pneumonia associated with asbestos. Thorax 1972; 27: 324–331.PubMedCrossRefGoogle Scholar
  267. 266.
    Stachura I, Singh G, Whiteside TL. Mechanisms of tissue injury in desquamative interstitial pneumonia. Am J Med 1980; 68: 733–740.PubMedCrossRefGoogle Scholar
  268. 267.
    Rosenow EC, O’Connell EJ, Harrison EG Jr. Desquamative interstitial pneumonia in children. Report of two cases. Am J Dis Child 1970; 120: 344–348.PubMedGoogle Scholar
  269. 268.
    Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801–809.PubMedCrossRefGoogle Scholar
  270. 269.
    Feigin DS, Friedman PJ. Chest radiography in desquamative interstitial pneumonitis: A review of 37 patients. AJR 1980; 134: 91–99.PubMedCrossRefGoogle Scholar
  271. 270.
    Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978; 298: 934–939.PubMedCrossRefGoogle Scholar
  272. 271.
    Bedrossian CWM, Kuhn C III, Luna MA, Conklin RH, Byrd RB, Kaplan PD. Desquamative interstitial pneumonia-like reaction accompanying pulmonary lesions. Chest 1977; 72: 166–169.PubMedCrossRefGoogle Scholar
  273. 272.
    Gaensler EA, Carrington CB, Coutu RE. Chronic interstitial pneumonias. Clin Notes Respir Dis 1972; 10: 316.Google Scholar
  274. 273.
    Valdivia E, Hensley G, WU J, LeRoy EP, Jaeschke W. Desquamative interstitial pneumonitis. Am J Pathol 1976;82:44a-45a (abstr).Google Scholar
  275. 274.
    Valdivia E, Helsney G, Wu J Leroy EP, Jaeschke W. Morphology and pathogenesis of desquamative interstitial pneumonitis. Thorax 1977; 32: 7–18.PubMedCrossRefGoogle Scholar
  276. 275.
    Bhagwat AG, Wentworth P, Conen PE. Observations on the relationship of desquamative interstitial pneumonia and pulmonary alveolar proteinosis in childhood: a pathologic and experimental study. Chest 1970; 58: 326–332.PubMedCrossRefGoogle Scholar
  277. 276.
    Wigger HJ, Berdon WE, Ores CN. Fatal desquamative interstitial pneumonia in an infant: case report with transmission and scanning electron microscopical studies. Arch Pathol Lab Med 1977; 101: 129–132.PubMedGoogle Scholar
  278. 277.
    Deodhar JD, Bhagwat AG. Desquamative interstitial pneumonia-like syndrome in rabbits. Arch Pathol Lab Med 1967; 84: 54–58.Google Scholar
  279. 278.
    Moore RD, Schoenberg MD. The response of histiocytes and macrophages in the lungs of rabbits injected with Freund’s adjuvant. Br J Exp Pathol 1964; 45: 488–497.PubMedGoogle Scholar
  280. 279.
    Bone RC, Wolfe J, Sobonya RE, et al. Desquamative interstitial pneumonia following long-term nitrofurantoin therapy. Am J Med 1976; 60: 697–701.PubMedCrossRefGoogle Scholar
  281. 280.
    Abraham JL, Hertzberg MA. Inorganic particulates associated with desquamative interstitial pneumonia. Chest 1981; 80: 675–705.CrossRefGoogle Scholar
  282. 281.
    FitzGerald MX, Carrington CB, Gaensler LA. Environmental lung disease. Med Clin North Am 1973; 57: 593–622.PubMedGoogle Scholar
  283. 282.
    Coates EO, Watson JHL. Diffuse interstitial lung disease in tungsten carbide workers. Ann Intern Med 1971; 75: 709–716.PubMedCrossRefGoogle Scholar
  284. 283.
    Herbert A, Sterling G, Abraham J, Corrin B. Desquamative interstitial pneumonia in an aluminum welder. Hum Pathol 1982; 13: 694–699.PubMedCrossRefGoogle Scholar
  285. 284.
    Canetti G. The tubercle bacillus in the pulmonary lesions of man. New York: Springer, 1955.Google Scholar
  286. 285.
    Patchefsky AS, Banner M, Freundlich IM. Desquamative intertitial pneumonia: significance of intranuclear viral-like inclusion bodies. Ann Intern Med 1971; 74: 322–327.PubMedCrossRefGoogle Scholar
  287. 286.
    McNary WE Jr, Gaensler EA. Intranuclear inclusion bodies in desquamative interstitial pneumonia: electron microscopic observations. Ann Intern Med 1971; 74: 404–407.PubMedCrossRefGoogle Scholar
  288. 287.
    Shortland JR, Durke CS, Crane WAJ. Electron microscopy of desquamative interstitial pneumonia. Thorax 1969; 24: 192–208.PubMedCrossRefGoogle Scholar
  289. 288.
    Tubbs RR, Benjamin SP, Reich NE, McCormack LJ, VanOstrand HS. Desquamative interstitial pneumonitis: cellular phase of fibrosing alveolitis. Chest 1977; 72: 159–165.PubMedCrossRefGoogle Scholar
  290. 289.
    Tubbs RR, Benjamin SP, Oborne DG, Barenberg S. Surface and transmission ultrastructural characteristics of desquamative interstitial penumonitis. Hum Pathol 1978; 9: 693–703.PubMedCrossRefGoogle Scholar
  291. 290.
    Fromm GB, Dunn LJ, Harris JO. Desquamative interstitial pneumonitis: Characterization of free intraalveolar cells. Chest 1980; 77: 552–554.PubMedCrossRefGoogle Scholar
  292. 291.
    Hogan PG, Donald KJ, McEvoy JDS. Immunofluorescence studies of lung biopsy tissue. Am Rev Rspir Dis 1978; 118: 537–545.Google Scholar
  293. 292.
    Dreisin RB, Schwarz MI, Theofilopoulos AN, Stanford RE. Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med 1978; 298: 353–357.PubMedCrossRefGoogle Scholar
  294. 293.
    Brentjens JR, O’Connell DW, Pawlowski IB, Hsu KC, Andres GA. Experimental immune compie diseases of the lung: the pathogenesis of a laboratory model resembling certain human interstitial lung diseases. J Exp Med 1974; 140: 105–125.PubMedCrossRefGoogle Scholar
  295. 294.
    Scherzer H, Ward P. Lung injury produced by immune complexes of varying composition. J Immunol 1978; 121: 947–952.PubMedGoogle Scholar
  296. 295.
    Liebow AA. New concepts and entities in pulmonary disease. In: Liebow AA, ed. The lung. International Academy of Pathology Monograph No 8. Baltimore: Williams & Wilkins, 1967: 332–365.Google Scholar
  297. 296.
    Liebow AA, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, eds. Frontiers of pulmonary pathology. New York: Grune and Stratton, 1968: 102–141.Google Scholar
  298. 297.
    Liebow AA. Definition and classification of interstitial pneumonias in human pathology. Prog Respir Dis (Basel) 1975; 8: 1–33.Google Scholar
  299. 298.
    Reddy PA, Gorelick DF, Christianson CS. Giant cell interstitial pneumonia (GIP). Chest 1970; 58: 319–325.PubMedCrossRefGoogle Scholar
  300. 299.
    Sokolowski JW, Cordray DR, Cantow EF, Elliott RC, Seal KB. Giant cell interstitial pneumonia. Report of a case. Am Rev Respir Dis 1972; 105: 417–420.PubMedGoogle Scholar
  301. 300.
    Hendrycy P, Dail DH. Giant cell interstitial pneumonia. Lab Invest 1978; 38: 348 (abstr).Google Scholar
  302. 301.
    Davison AG, Haslam PL, Corrin B, et al. Interstitial lung disease and asthma in hard metal workers: bronchoalveolar lavage, unitrastructural and analytical findings and results of bronchial provocation tests. Thorax 1983; 38: 119–128.PubMedCrossRefGoogle Scholar
  303. 302.
    Abraham JL. Exposure to hard metal. Chest 1985; 87: 554 (letter).Google Scholar
  304. 303.
    Cullen MR. Exposure to hard metal. Chest 1985; 87: 554 (answer to letter).Google Scholar
  305. 304.
    Sprince NL, Chamberlin RI, Hales CA, Weber AL, Kazemi H. Respiratory disease in tungsten carbide production workers. Chest 1984; 84: 549–557.CrossRefGoogle Scholar
  306. 305.
    Schepers GWH. The biologic action of particulate cobalt metal: Studies on experimental pulmonary histopathology. A.M.A. Arch Indust Health. 1955; 12: 127–133.Google Scholar
  307. 306.
    von Hansemann D. Uber malakoplakie der Harnblase. Virchows Arch Pathol Anat 1903; 173: 302–308.CrossRefGoogle Scholar
  308. 307.
    Michaelis L, Gutmann C. Uber einschluse in Blasentumoren. Z Klin Med 1902; 47: 208–215.Google Scholar
  309. 308.
    Damjanov I, Katz SM. Malakoplakia. Pathol Annu 1981; 16: 103–126.Google Scholar
  310. 309.
    Gupta RK, Schuster RA, Christian WD. Autopsy findings in a unique case of malakoplakia: a cytoimmunohistochemical study of Michaelis-Gutmann bodies. Arch Pathol Lab Med 1972; 93: 42–48.Google Scholar
  311. 310.
    Colby TW, Hunt S, Pelzmann K, Carrington CB. Malakoplakia of the lung: a report of two cases. Respiration 1980; 39: 295–299.PubMedCrossRefGoogle Scholar
  312. 311.
    Hodder RV, St. George-Hyslop P, Chalvardjian A, Bear RA, Thomas P. Pulmonary malakoplakia. Thorax 1984; 39: 70–71.PubMedCrossRefGoogle Scholar
  313. 312.
    Crouch E, White V, Wright J, Churg A. Malakoplakia mimicking carcinoma metastatic to lung. Am J Surg Pathol 1984; 8: 151–156.PubMedCrossRefGoogle Scholar
  314. 313.
    Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 1907; 18: 382–391.Google Scholar
  315. 314.
    Black-Schaffer B. The tinctorial demonstration of a glycoprotein in Whipple’s disease. Proc Soc Exp Biol Med 1949; 72: 225–227.PubMedGoogle Scholar
  316. 315.
    Sieracki JC. Whipple’s disease: observation on systemic involvement: I. Cytologic observations. Arch Pathol Lab Med 1958; 66: 464–467.Google Scholar
  317. 316.
    Yardley JH, Fleming WH II. Whipple’s disease: a note regarding PAS-positive granules in the original case. Bull Johns Hopkins Hosp 1961; 109: 76–79.PubMedGoogle Scholar
  318. 317.
    Haubrich WS, Watson JHL, Sierachi JC. Unique morphologic features of Whipple’s disease. A study by light and electron microscopy. Gastroenterology 1960; 30: 459–467.Google Scholar
  319. 318.
    Cohen AS, Schimmel EM, Holt PR, Isselbacher KJ. UItrastructural abnormalities in Whipple’s disease. Proc Soc Exp Biol Med 1960; 205: 411–414.Google Scholar
  320. 319.
    Chears WC Jr, Ashworth CT. Electron microscopic study of the intestinal mucosa in Whipple’s disease. Demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology 1961; 41: 129–138.PubMedGoogle Scholar
  321. 320.
    Yardley JH, Hendrix TR. Combined electron and light microscopy on Whipple’s disease: demonstration of “bacillary bodies” in the intestine. Bull Johns Hopkins Hosp 1961; 109: 80–98.PubMedGoogle Scholar
  322. 321.
    Paulley JW. A case of Whipple’s disease (intestinal lipodystrophy). Gastroenterology 1952; 22: 128–133.PubMedGoogle Scholar
  323. 322.
    Ashworth CT, Douglas FC, Reynolds RC, Thomas PJ. Bacillus-like bodies in Whipple’s disease; disappearance with clinical remission after antibiotic therapy. Am J Med 1964; 37: 481–490.PubMedCrossRefGoogle Scholar
  324. 323.
    Plummer K, Russi S, Harris WH Jr, Caravati CM. Lipophagic intestinal granulomatosis (Whipple’s disease): clinical and pathologic study of thirty-four cases, with special reference to clinical diagnosis and pathogenesis. Arch Intern Med 1950; 86: 280–310.CrossRefGoogle Scholar
  325. 324.
    Maizel H, Ruffin JM, Dobbins WO III. Whipple’s disease: a review of 19 patients from one hospital and a review of the literature since 1950. Medicine (Baltimore) 1970; 49: 175–205.Google Scholar
  326. 325.
    Clayey RL, Tomkins WAF, Muckle TJ, Anderson H, Rawls WE. Isolation and characterization of an aetiologic agent in Whipple’s disease. Br Med J 1975; 3: 568–570.CrossRefGoogle Scholar
  327. 326.
    Sieracki JC, Fine G. Whipple’s disease-observations on systemic involvement. II. G.oss and histologic observations. A.M.A. Arch Path 1959; 67: 81–93.PubMedGoogle Scholar
  328. 327.
    Enzinger FM, Helwig EB. Whipple’s disease. A review of the literature and report of fifteen cases. Virchow Arch Path Anat 1963; 336: 238–269.Google Scholar
  329. 328.
    Pastor BM, Geerken RG. Whipple’s disease presenting as pleuripericarditis. Am J Med 1973; 55: 827–831.PubMedCrossRefGoogle Scholar
  330. 329.
    Apperly FL, Copley EL. Whipple’s disease (lipophagia granulomatosis). Gastroenterology 1943; 1: 461–470.Google Scholar
  331. 330.
    Rodarte JR, Garrison CO, Holley KE, Fontana RS. Whipple’s disease simulating sarcoidosis: a case with unique clinical and histological features. Arch Intern Med 1972; 129: 479–482.PubMedCrossRefGoogle Scholar
  332. 331.
    James TN, Bulkley BH. Whipple bacilli within the tunica media of pulmonary arteries. Chest 1984; 86: 454–458.PubMedCrossRefGoogle Scholar
  333. 332.
    Spain DM, Kliot DA. PAS and Sudan positive pulmonary emboli in Whipple’s disease. Gastroenterology 1962; 43: 202–205.PubMedGoogle Scholar
  334. 333.
    Winberg CD, Rose ME, Rappaport H. Whipple’s disease of the lung. Am J Med 1978; 65: 873–880.PubMedCrossRefGoogle Scholar
  335. 334.
    Crocker AC, Farber S. Niemann-Pick disease: a review of 18 patients. Medicine (Baltimore) 1958; 37: 1–95.CrossRefGoogle Scholar
  336. 335.
    Lynn R, Terry RD. Lipid histochemistry and electron microscopy in adult Niemann-Pick disease. Am J Med 1964; 37: 987–994.PubMedCrossRefGoogle Scholar
  337. 336.
    McCusker JJ, Parsons DB. Niemann-Pick disease: report of two cases in siblings including the necropsy and histochemical findings in one. Arch Pathol Lab Med 1962; 74: 127–136.Google Scholar
  338. 337.
    Lachman R, Crocker A, Schulman J, Strand R. Radiological findings in Niemann-Pick disease. Radiology 1973; 108: 659–664.PubMedGoogle Scholar
  339. 338.
    Skikne MI, Prinsloo I, Webster I. Electron microscopy of lung in Niemann-Pick disease. J Pathol 1972; 106: 119–122.PubMedCrossRefGoogle Scholar
  340. 339.
    Terry RD, Sperry WM, Brodoff B. Adult lipidosis resembling Niemann-Pick disease. Am J Pathol 1954; 30: 263285.Google Scholar
  341. 340.
    Long RG, Lake BD, Pettit JE, Scheuer PJ, Sherlock S. Adult Niemann-Pick disease: its relationship to the syndrome of the sea-blue histiocyte. Am J Med 1977; 62: 627–635.PubMedCrossRefGoogle Scholar
  342. 340a.
    Lever AML, Ryder JB. Cor pulmonale in an adult secondary to Niemann-Pick disease. Thorax 1983; 38: 873–874.PubMedCrossRefGoogle Scholar
  343. 341.
    Rywlin AM, Hernandez JA, Chastain DE, Pardo V. Ceroid histiocytosis of spleen and bone marrow in idiopathic thrombocytopenic purpura (ITP): a contribution to the understanding of the sea-blue histiocyte. Blood 1971; 37: 587–593.PubMedGoogle Scholar
  344. 341a.
    Beltrami CA, Bearzi I, Fabris G. Storage cells of spleen and bone marrow in thalassemia: an ultrastructural study. Blood 1973; 41: 901–912.PubMedGoogle Scholar
  345. 342.
    Lüllmann H, Lüllmann-Rauch R, Wasserman O. Drug-induced phospholipidoses. CRC Grit Rev Toxicol 1975; 4: 185–218.Google Scholar
  346. 343.
    Schneider EL, Epstein CJ, Kaback MJ, Brandes D. Severe pulmonary involvement in adult Gaucher’s disease: report of three cases and review of the literature. Am J Med 1977; 63: 475–480.PubMedCrossRefGoogle Scholar
  347. 344.
    Smith RRL, Hutchins GM, Sack GH Jr, Ridolfi RL. Unusual cardiac, renal and pulmonary involvement in Gaucher’s disease: interstitial glucocerebrosidal accumulation, pulmonary hypertension and fatal bone marrow embolization. Am J Med 1978; 65: 352–360.PubMedCrossRefGoogle Scholar
  348. 345.
    Wolson AH. Pulmonary findings in Gaucher’s disease. AJR 1975; 123: 712–715.CrossRefGoogle Scholar
  349. 346.
    Peters SP, Lee RE, Glew RH. Gaucher’s disease: a review. Medicine (Baltimore) 1977; 56: 425–442.Google Scholar
  350. 347.
    Bartimmo EE Jr, Guisan M, Moser KM. Pulmonary involvement in Fabry’s disease: a reappraisal. Follow-up of a San Diego kindred and review of the literature. Am J Med 1972; 53: 755–764.PubMedCrossRefGoogle Scholar
  351. 348.
    Rosenberg DM, Ferrans VJ, Fulmer JD, et al. Chronic airflow obstruction in Fabry’s disease. Am J Med 1980; 68: 898–905.PubMedCrossRefGoogle Scholar
  352. 349.
    Kariman K, Singletary WV Jr, Sieber HO. Pulmonary involvement in Fabry’s disease. Am J Med 1978; 64: 91 1912.Google Scholar
  353. 350.
    Bagdade JD, Parker F, Ways PO, Morgan TE, Lagunoff D, Eidelman S. Fabry’s disease: a correlative clinical, morphologic and biochemical study. Lab Invest 1968; 18: 681–688.PubMedGoogle Scholar
  354. 351.
    Garay SM, Gardella JE, Fazzini EP, Goldring RM. Hermansky-Pudlak syndrome: pulmonary manifestations of a ceroid storage disorder. Am J Med 1979; 66: 737–747.PubMedCrossRefGoogle Scholar
  355. 352.
    Reinelä A. Perivascular xanthogranulomatosis in the lungs of diabetic patients. Arch Pathol Lab Med 1976; 100: 542–543.Google Scholar
  356. 353.
    Caplan H. A case of endocardial fibroelastosis with features of glycogen storage disease. J Pathol Bacteriol 1958; 76: 77–82.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • David H. Dail

There are no affiliations available

Personalised recommendations